Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis - Maria, Mazzitelli; Maraolo, Alberto Enrico; Cozzolino, Claudia; Sasset, Lolita; Ferrari, Anna; Basso, Monica; Vania, Eleonora; Bonadiman, Nicola; Scaglione, Vincenzo; Cattelan, Anna Maria (European journal of medical research, 2024)
Keywords: Adenosine Monophosphate - analogs & derivatives; Adenosine Monophosphate - therapeutic use; Aged; Alanine - administration & dosage; Alanine - analogs & derivatives; Alanine - therapeutic use; Antiviral Agents - administration & dosage; Antiviral Agents - therapeutic use; Combined treatment; COVID-19 - mortality; COVID-19 Drug Treatment; Drug Therapy, Combination; Early treatment; Female; Hospitalization - statistics & numerical data; Humans; Immunocompromised Host; Male; Middle Aged; Monoclonal antibodies; Monotherapy; Mortality; Propensity Score; Retrospective Studies; Ritonavir - therapeutic use; SARS-CoV-2; Severe immunocompromised patients; Treatment Outcome; SARS-CoV-2; Combined treatment; Severe immunocompromised patients; Early treatment; Monotherapy